STOCKHOLM, April 27, 2017 /PRNewswire/ -- InDex
Pharmaceuticals Holding AB (publ) today publishes the Annual Report
for 2016. The Annual Report (in the Swedish language) is attached
as a PDF and is available on the company's website,
www.indexpharma.com.
The printed Annual Report is mailed to shareholders and other
stakeholders who specifically request it. Send request to
info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding
AB (publ), Tomtebodavägen 23a, 171 77 Stockholm.
For more information:
Peter
Zerhouni
CEO
Phone: +46-8-508-847-35
E-mail: peter.zerhouni@indexpharma.com
InDex Pharmaceuticals in brief
InDex is a pharmaceutical development company focusing on
immunological diseases where there is a high unmet medical need for
new treatment options. The company's foremost asset is the drug
candidate cobitolimod, which is in late stage clinical development
for the treatment of moderate to severe active ulcerative colitis -
a debilitating, chronic inflammation of the large intestine. InDex
has also developed a platform of patent protected discovery stage
substances, so called DNA based ImmunoModulatory Sequences (DIMS),
with the potential to be used in treatment of various immunological
diseases.
InDex is based in Stockholm,
Sweden. The company's shares are traded on Nasdaq First
North Stockholm. Redeye AB is the company's Certified Adviser. For
more information, please visit www.indexpharma.com
Publication
This information is information that InDex Pharmaceuticals
Holding AB (publ) is obliged to make public pursuant to the Swedish
Securities Market Act. The information was submitted for
publication through the agency of the contact person set out above
at 8:00 CET on April 27, 2017.
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/index-pharmaceuticals/r/index-pharmaceuticals-holding-ab--publ--publishes-annual-report-for-2016,c2251262
The following files are available for download:
http://mb.cision.com/Main/9612/2251262/664916.pdf
|
InDex Pharmaceuticals
Holding AB Annual Report 2016 (in Swedish)
|
http://mb.cision.com/Public/9612/2251262/9799389df47913d0.pdf
|
PR InDex Annual
Report 2016 eng final
|